NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The Metals Company (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today announced that it will host a conference call on Thursday, November 14, 2024, to provide an update on third quarter financial results and recent corporate developments.
Third Quarter 2024 Conference Call Details
Date: | Thursday, November 14, 2024 |
Time: | 4:30 p.m. ET |
Audio-only Dial-in: | Register Here |
Virtual webcast with slides: | Register Here |
The virtual webcast will be available for replay in the ‘Investors’ tab of the Company’s website under ‘Investors’ > ‘Media’ > ‘Events and Presentations’, approximately two hours after the event.
About The Metals Company
The Metals Company is an explorer of lower-impact battery metals from seafloor polymetallic nodules, on a dual mission: (1) supply metals for the global energy transition with the least possible negative impacts on planet and people and (2) trace, recover and recycle the metals we supply to help create a metals commons that can be used in perpetuity. The Company through its subsidiaries holds exploration and commercial rights to three polymetallic nodule contract areas in the Clarion Clipperton Zone of the Pacific Ocean regulated by the International Seabed Authority and sponsored by the governments of Nauru, Kiribati, and the Kingdom of Tonga.
More information is available at www.metals.co.
Contacts
Media | media@metals.co
Investors | investors@metals.co
-
The Metals Company Announces Third Quarter 2024 Corporate Update Conference Call for Thursday, NovemNEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The Metals Company (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metal2024-11-07
-
在超市货架前停留不超过 20 秒这是普通消费者在决定是否购买产品前所花费的最长时间,即使对于水果和蔬菜也是如此 费拉拉,意大利, Nov. 07, 2024 (GLOBE NEWSWIRE) -- 消费者在货架前停留的平2024-11-07
-
AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the TreatmenResearch Triangle Park, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 20232024-11-07
-
Cavli Wireless is all set to introduce the LTE Cat 4 CQS315 Smart Module at Electronica Munich 2024The CQS315 Smart IoT Module is engineered for high-performance applications, delivering versatile multimedia capabilities ideal for vehicle-mounted2024-11-07
-
MedSource Labs Announces Groundbreaking Digital Training Assets for IV CathetersMedSource Labs Unveils the most intensive remote training tools available to medical professionals, distributors and students. [Minneapolis, Minnesot2024-11-07